è¶ èš³åã¢ããªã«P瀟å¥çŽãšDNAæ··å ¥ã®éæ³æ§ã®è©Šè«
â åã¢ããªã«å¥çŽé瀺
ãåã¢ããªã«ã®å¥çŽæžé瀺ãè¡ãããŠãããã°ããçµã¡ãŸãããããã€ãã®ã¬ãŽã¥ãŒïŒåæïŒããããŸããããã®å¥çŽã®ãã°ãã«ã¯ãã©ãçããŠããªãããã§ãã
ã衚é¢çã«æžãããŠããæèšãã·ã¥ãŒã«ã«èªãè¶
èš³ã詊ã¿ãªããšããã®äž»æš©äŸµå®³åã³ãã¥ã«ã³ãã«ã¯éç¯ã¯èŠããŠããªãã®ãããã¡ãã®ç¬èªã®èª¿æ»ã§èŠããŠããŸããã
ãä»åã¯ãè¶
èš³ã®è¡ãã€ã詊è«ãšããŠããã®éæ³ã®æ³çè©äŸ¡ã詊ã¿ãŠã¿ãŸãã衚é¢çãªæèšã§ã¯ãªãèªã¿ãªã®ã§ããããŸã§è©Šè«ãšããäºã«ãªããŸããã詊è«ãšããŠã¯ãåæ³äžéºäŒå䟵害ãèªããããŠããªãçŸç¶ã倧ããªåé¡ãçãã§ãããšããæ¹åæ§ã«ãªãããã§ããïŒãã®è«èã¯å®å¹çãªæ³åŸã®å
ã«ããã®ã§çŸå®çãªæ³çãªå®å¹æ§ã«é¢ããŠã¯ä»åŸã®æ³çãªæçãå¿
èŠã§ããïŒ
ãŸãã¯P瀟åã¢ããªã«å¥çŽã®èªè§£ããã鹿å çã®åç»ã
鹿å ç2023.9.19
â å°åå°çŠç°å»é¢_çŠç°äžäž.MECé£Dr (@fseiichizb4) September 19, 2023
10幎éç§å¯ã®ãã¡ã€ã¶ãŒãšã®äžå¹³çå¥çŽãäžçã®ããã«åã¢ããªã«ãå ¬éããã
ãæååæãæ¯æ§è©Šéšããã£ãŠã¯ãããªã
ãã¯ã¯ãã³ã®é·æçãªæå¹æ§ãå®å šæ§ã¯äžæ
ãå®å šã§ããªããæå¹ã§ããªãããšãæ¿ç¥ããŠäœ¿ã£ãŠãã ããã⊠https://t.co/MRTzAjKlZi pic.twitter.com/Pfj66fiqiM
äŸ¡æ Œãšããäž»ã§ããã®æ³ç責任ã®è§£éã¯è¡ã£ãŠããªãããã§ãã
以äžã«ããã«è§£éãå
ãžé²ããããšã詊ã¿ãŸã
â¡ãªã³ã¯
â åã¢ããªã«å¥çŽãªã³ã¯
ã
https://healthjusticeinitiative.org.za/wp-content/uploads/2023/09/OCRPfizer-1_Redacted.pdf
â¡å¥çŽã®è£è¶³
https://healthjusticeinitiative.org.za/wp-content/uploads/2023/09/OCRPfizer-3_no-sign.pdf
以äžã®ãªã³ã¯ãããå¥çŽã®å
責ãšãããšãããè¶
èš³ããŠã¿ãŸãã
â¢å¥çŽæžã®æ¡é ïŒäžèšãªã³ã¯ããæç²ïŒ
â ã Government acknowledges that its indemnification obligations under this Agreement are (1) expressly in addition to, and not limited by, any Privileges and Immunities, and (2) do not waive or relinquish Indemnitees' rights to any Privileges and Immunities.ãïŒäžèšâ¡ã®å¥çŽè£è¶³ãããããããäžèšã®ãã®ã¯â å¥çŽãªã³ã¯ã®æ¡é
ïŒ
ãæ¿åºã¯ãæ¬å¥çŽã«åºã¥ãè£å矩åãã(1) ç¹æš©ããã³å
è²¬ã«æç€ºçã«è¿œå ããããã®ã§ãããç¹æš©ããã³å
責ã«ãã£ãŠå¶éããããã®ã§ã¯ãªãããšã(2) æ¿åºã®è£åããã¡ã€ã¶ãŒã®ç¹æš©ããã³å
è²¬ã®æš©å©ãæŸæ£ãŸãã¯ç Žæ£ãããã®ã§ã¯ãªãããšãèªãããã
âããã¡ã€ã¶ãŒã®ç¹æš©ãšå
責ãšããŠãæ¿åºãã¯ã¯ãã³ã«å¯ŸããŠããä¿èšŒã¯ããã¡ã€ã¶ãŒã®è²¬ä»»ã«åºã¥ããŠãªããããã®ã§ãªããšããããã€ãŸããæ¿åºãè£åããŠããã¡ã€ã¶ãŒãæ³çã«æ¡ã§ãããšè©äŸ¡ãããããã§ã¯ãªããã
ïŒè¶
èš³ïŒããããæ»ãã§ãè¢«å®³ææžããŠããã¡ã€ã¶ãŒã¯æªããªããšããããïŒçŸè¡æ¥æ¬ã®è¢«å®³è
ææžå¶åºŠãšåãéçšïŒ
â¡ãPurchaser hereby agrees to indemnify, defend and hold
harmless Pfizer, BioNTech, each of their Affiliates, contractors, sub-contractors, licensors, licensees, sub-licensees, distributors, contract manufacturers, services providers, clinical
trial researchersã
âã賌å
¥è
ïŒæ¿åºïŒã¯ãæ¬å¥çŽã«ããããã¡ã€ã¶ãŒããã€ãªãšãããã¯ããã®åé¢é£äŒç€Ÿãè«è² æ¥è
ãäžè«æ¥è
ãã©ã€ã»ã³ãµãŒãã©ã€ã»ã³ãµãŒãããã³ãã®é¢é£äŒç€Ÿãè£åããæè·ããæå®³ãäžããªãããšã«åæãããã
ïŒè¶
èš³ïŒããã¹ãŠã¯æ¿åºã責任ãè² ãã
â¢ãPurchaser hereby agrees to indemnify, defend and hold
harmless Pfizer, BioNTech, each of their Affiliates,,,,,from whether sounding in contract, tort (delict), intellectual property, or any other theory, and whether legal, statutory, equitable or otherwise by any natural or legal person (collectively, "Losses") caused by, arising out of, relating to, or resulting from the Vaccineã(æç²ïŒ
âã賌å
¥è
ïŒæ¿åºïŒã¯ãæ¬å¥çŽã«ããããã¡ã€ã¶ãŒããã€ãªãšãããã¯ãããå¥çŽäžãäžæ³è¡çºäžã®ãããã責任ããå®ããïŒèŠèš³ïŒ
âïŒè¶
èš³ïŒãããããçç±ã§èšŽèšãèµ·ããããšã¯èš±å®¹ãããæ¿åºãåŠçããã
â£ãmaintain a no-fault compensation fund sufficient to undertakeãâãç¡é倱ä¿éå¶åºŠãäœãã
âïŒè¶
èš³ïŒãæ¿åºãä¿èšŒããŠããã¡ã€ã¶ãŒåã³æ¿åºã«è²¬ä»»ãããããã§ãªããšããã
â€ãWaiver of Sovereign Immunity. Purchaser, on behalf of itself and the Republic of South Africa, expressly and irrevocably waives any right of immunity which either it or its assets
may have or acquire in the futureãâã䞻暩å
è²¬ã®æŸæ£ã賌å
¥è
ã¯ã賌å
¥è
èªèº«ããã³åã¢ããªã«å
±ååœã代衚ããŠãæç€ºçãã€åæ¶äžèœãªåœ¢ã§ã賌å
¥è
ãŸãã¯ãã®è³ç£ã®ãããããå
責ãããæš©å©ãæŸæ£ãããã
âïŒè¶
èš³ïŒãå¥çŽã§åœã¯ä¹ã£åãããŸãã
â¥ãConfidential Information with at least the same degree of care as it holds its own confidential or proprietary information of like kind, which shall be no less than a reasonable degree of careãâããã¡ã€ã¶ãŒãšã®å¥çŽã¯äŒç€Ÿã®æ©å¯ã§ã¯ãªããèªåœã®æ©å¯ãšåãããã«æ±ããŸããã
âïŒè¶
èš³ïŒãå¥çŽã§ãã§ã«åœã¯ä¹ã£åãããŠããŸãããã¡ã€ã¶ãŒã®æ©å¯ãåœå®¶æ©å¯ã«åŒ·å¶çã«æå®ããŸããšããäºã
â£å¥çŽã®ãŸãšã
P瀟ã«å¯ŸããŠè£åãæ±ããããšåã³ãP瀟ã®è²¬ä»»ãåãããšã¯ã§ããªãããšããããã«ãªãããã§ãã
â€DNAæ··å ¥åé¡ãšåæ³
ã補é ç©è²¬ä»»ã¯ãåœç¶ãããšããŠããã§ã¯æ±ããã«ãä»®ã«DNAãæ··å
¥ããŠåæã«æ¹å€ãããŠããå Žåãäžèšè£åå¥çŽã§ã©ããªãã®ãã詊è«ãšããŠè¿°ã¹ãŠã¿ãŸãã
ãè³åŠäž¡èŒªããããŸãããä»®ã«DNAæ··å
¥ãããã人ã®DNAãå€ããããå Žåãéæ³ãªã®ãã©ãããšèšãã°ãåæ³äžéºäŒåæ¹å€ã眪ã«åãæ³åŸã¯çŽæ¥çã«ã¯ãªãã§ããïŒãªã³ã¯ããïŒ
ãhttp://hokuga.hgu.jp/dspace/bitstream/123456789/1697/1/KANMOTO.pdf
ãŸãããåæã«éºäŒåãæžãæãããããªããŠããšãè¡ããããšã¯æ³ã·ã¹ãã ãèããŠããªãã£ãããã§ãã
ããã¡ãããæ¯ãã³ãæãããŠãäœæã§ããç°åžžãåºãå Žåã«ã¯å·å®³ãªã©ã®éæ³ãçºçããã§ãããããä»®ã«DNAæ¹å€ãèµ·ããŠããŠãäœèª¿ã«ç°åžžããªãå Žåãåæ³äžã®å·å®³ãããã¯æ®ºäººæªéãåããã®ããšèšãã°ãéºäŒåã®æ¹å€ã®åæ³äžã®äœçœ®ã¥ãããããŸããªããããã€ã¬ã¯ãã«ç¯çœªãæç«ãããã©ããã¯æ³çãªè§£éãå¿
èŠã«ãªããŸãã
ãããããã°ã¬ãŒãŸãŒã³ãå©çšããŠä»åã®æ¯ãã³ã宿œãããŠãããšæãããŸãã
ãæ°äºã®æå®³è³ åã§ã®éæ³ã®æ³çæ§æã®ä»æ¹ã¯æš©å©æ§æã§èªå·±æ±ºå®æš©ãåã«åºãã°ãéæ³æ§ãèªå®ã§ããå¯èœæ§ã¯ããã§ãããããåæ³äžã®ç¯çœªã®æç«ã¯ãè°è«ã®æžŠäžã«ãããæç«ã¯è§£éãšçœªåæ³å®äž»çŸ©ïŒè¡çºã®åã«ç¯çœªãšããŠèŠå®ãããŠããªããšäºåŸçåŠçœ°ã«ãªãèš±ãããªãããšïŒã«ããæç«ã®å¹
ã¯çããªãããã§ãã
ã
â¥DNAæ··å ¥åé¡ãšå¥çŽäžã®è£å
ãä»®ã«æ¯ãã³DNAæ··å
¥åé¡ã§ãç°åžžãæããããªããŠããDNAãå€ããããŠããå Žåãå¥çŽã«ãããè£åãã©ããªãã®ãïŒãšããåé¡ãçºçããŸãã
ãäžèšå¥çŽã®æ¡é
ãäžççã«äœ¿ãããŠãããšããããæ¥æ¬ã§ããã®æ¡é
ã§ããããšã«ãªããå¥çŽã«åºã¥ããè£åã®æš©å©ã¯â ããã¡ã€ã¶ãŒã®å
責ã¯èšŽèšã®æš©å©ãŸã§å¥ªããã®ã§ã¯ãªãããšããâ¡ãããããçç±ã§èšŽèšãèµ·ããããšã¯åŠå®ãããŠããªãããšãããŠããããšã«ãããäœèª¿ã«ç°åžžããªããŠãDNAã®æ¹å€ãè¡ãããŠããå Žåã蚎èšã¯æèµ·ã§ããããšã«ãªãããã§ãã
ããã®å Žåã蚎èšãèµ·ããå°çšç¯å²ã¯ããã¹ãŠã®æ¯ãã³æ¥çš®è
ã«åºããããšãæ³å®ãããŸãã
ãããã¯ãã°ãïœïœãã¹ãŠã®æ¥çš®è
ãæå®³ãæ±ããŠããããäŒç€Ÿãçµäºã§ããïœïœ(ãã®å Žåããããã補åãã®ãã®ãæ¬ é¥ã§åœå®¶ãšã®å
責ãæå¹ãçåã§ãïŒ
ãããã§ãåé¡ãã©ãã«ãããªããŠã¯ãããŸããã被害è
ã®å®çŸ©ããæ¯ãã³ãæ¥çš®ããŠå¥åº·ã害ãããã®ã«ããå¿
èŠããããŸãã
ã被害è
ãšåŒã°ãããã®ãå¥åº·ã«åœ±é¿ããããã®ã«éå®ããããšã«ãããæ³çãªãªã¹ã¯ãåºããã®ãé¿ããããšãã§ããããã«ãªããŸãã
ãäŸãã°ãã®æçš¿
æ¥çš®æšå¥švså察ã§ã¯åã¡ç®ãç¡ã
â ãã¹ã¿ãŒã (å ç§å») MD PhD (@tostadas_Md_PhD) October 5, 2023
被害è 匟å§vsææžãšèšãè«ç¹ã«ç§»è¡ããŠããã£ãšç¶æ³ãå€ãã£ã
ãããçè§£ããã«
æ¥é°ã®ç°åœ¢è ãšããŠå察ã蚎ããŠããææãæãããè ã¯ãæ®å¿µãªããæŸçœ®ãã¹ãã
ä»ã¯ããšã«ãã
ãæšå¥šæŽŸãããã«ææžã«åŸæã ã£ãããå°è±¡ã¥ãããã¹ãã
ããã°ãžã£ããŒãºåé¡ãå ¬å®³ãå·®å¥ãšèšã£ã
â ãã¹ã¿ãŒã (å ç§å») MD PhD (@tostadas_Md_PhD) October 5, 2023
ãããããªãäžæ¡çã«æããã被害è ã
vs
ãå§åçãªæš©åã®æšªæŽã
ã«èœãšã蟌ãã¹ãã
ãæ¯ãã³ã®åé¡ãã被害è
ïœSæš©åã®æšªæŽãã«èœãšã蟌ãããšã«ããããã¹ãŠã®äººéãéºäŒåã«ãã¡ãŒãžãåããŠãããããããªãéæ³ããç®ãèããçµæã«ãªã£ãŠããŸãã
ãæ¯ãã³ã®çã®ã€ãããã©ãã«ããããããéãªçè§£è
ãªããããã¯åé¡ãããããããŠãããšæããããšã«ãªãã¯ãã§ãã
ãå¥åº·è¢«å®³è
ææžã¯ãã¡ããéºäŒè¢«å®³è
ã¯ãã¹ãŠã®äººã«èµ·ããããã§ããããã©ãããã°ããã®ããçã®åé¡ãšããŠæ¯ãã³ã«ã¯ä»ããŸãšããŸãã
âŠãã¥ã«ã³ãã«ã¯
ã以äžããããã詊è«ãæžããŠããŸããããåæã«éºäŒåãæžãæããããæ³çäºäŸã¯ä»ãŸã§ãªããšæãããã®ã§ãæ³çã«æªæœæã®å±éºãªç¶æ
ã§ãã
ããã¥ã«ã³ãã«ã¯ç¶±é ã§ã®äººäœå®éšã®çŠæ¢ããã®äººéã«å¯Ÿãã眪ã§ã®å³ç²ãªåŠçœ°ãèµ·ããã¹ãã§ãããåœéåäºæ³ã§å®ããããŠããŠãå®éã«ã¯èµ·åãã«ããã§ãã
ããŸãã¯ãåæ³ã§ã®å·å®³çœªã®æç«ãèµ·ããåŸãã®ãïŒãšãããšããã ãšæããŸãã